These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1310741)
1. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain. Benavides J; Peny B; Allen J; Scatton B J Pharmacol Exp Ther; 1992 Feb; 260(2):896-901. PubMed ID: 1310741 [TBL] [Abstract][Full Text] [Related]
2. In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine. Hashimoto K; Scheffel U; London ED Synapse; 1995 May; 20(1):85-90. PubMed ID: 7624833 [TBL] [Abstract][Full Text] [Related]
3. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. Coughenour LL; Cordon JJ J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. Largent BL; Gundlach AL; Snyder SH J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248 [TBL] [Abstract][Full Text] [Related]
5. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. Carter CJ; Lloyd KG; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016 [TBL] [Abstract][Full Text] [Related]
6. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile. Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461 [TBL] [Abstract][Full Text] [Related]
7. [3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo. Watanabe M; Rominger D; Hurt SD; De Souza EB; Tam SW J Pharmacol Exp Ther; 1993 Sep; 266(3):1541-8. PubMed ID: 8371156 [TBL] [Abstract][Full Text] [Related]
8. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. Wu XZ; Bell JA; Spivak CE; London ED; Su TP J Pharmacol Exp Ther; 1991 Apr; 257(1):351-9. PubMed ID: 1850471 [TBL] [Abstract][Full Text] [Related]
9. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain. Weissman AD; Broussolle EP; London ED J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560 [TBL] [Abstract][Full Text] [Related]
10. Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autoradiography. Aanonsen LM; Seybold VS Synapse; 1989; 4(1):1-10. PubMed ID: 2549651 [TBL] [Abstract][Full Text] [Related]
11. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y; Mash D; Zhang SH; Stein I Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660 [TBL] [Abstract][Full Text] [Related]
12. In vivo labeling of phencyclidine (PCP) receptors with 3H-TCP in the mouse brain. Maurice T; Vignon J J Neurosci Res; 1990 Jul; 26(3):377-85. PubMed ID: 2168951 [TBL] [Abstract][Full Text] [Related]
13. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20. Kushner L; Zukin SR; Zukin RS Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188 [TBL] [Abstract][Full Text] [Related]
14. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality. Sircar R; Nichtenhauser R; Ieni JR; Zukin SR J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795 [TBL] [Abstract][Full Text] [Related]
15. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of [3H]ifenprodil binding in rat brain. Hashimoto K; Mantione CR; Spada MR; Neumeyer JL; London ED Eur J Pharmacol; 1994 Jan; 266(1):67-77. PubMed ID: 7907988 [TBL] [Abstract][Full Text] [Related]
18. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits. Coughenour LL; Barr BM J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375 [TBL] [Abstract][Full Text] [Related]
19. Ifenprodil and SL 82.0715 potently inhibit binding of [3H](+)-3-PPP to sigma binding sites in rat brain. Contreras PC; Bremer ME; Gray NM Neurosci Lett; 1990 Aug; 116(1-2):190-3. PubMed ID: 1979666 [TBL] [Abstract][Full Text] [Related]
20. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex. Berger ML; Rebernik P J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]